CDC-Authored Genomics and Precision Health Publications Database

---

Last data update: Apr 18, 2025. (Total: 6649 publications)

All Cancer Diabetes Economic Equity Environmental FHH HLBS ID Implementation ND PGx PI Rare RCH dataset

Filtered By: Select to fine-tune your search Year Journal

Next

Records 1-30 (of 31 Records)

Query Trace: Heneine W[original query]
High HIV diversity, recombination, and superinfection revealed in a large outbreak among persons who inject drugs in Kentucky and Ohio, USA Switzer WM , Shankar A , Jia H , Knyazev S , Ambrosio F , Kelly R , Zheng H , Campbell EM , Cintron R , Pan Y , Saduvala N , Panneer N , Richman R , Singh MB , Thoroughman DA , Blau EF , Khalil GM , Lyss S , Heneine W . Virus Evol 2024 10 (1) veae015
Transmitted Drug Resistance Among HIV-1 Diagnoses in the United States, 2014-2018. McClung RP , Oster AM , Ocfemia MCB , Saduvala N , Heneine W , Johnson JA , Hernandez AL . Clin Infect Dis 2021 74 (6) 1055-1062
Natural selection favoring more transmissible HIV detected in United States molecular transmission network. Wertheim JO , Oster AM , Switzer WM , Zhang C , Panneer N , Campbell E , Saduvala N , Johnson JA , Heneine W . Nat Commun 2019 10 (1) 5788
HIV-1 genetic diversity to estimate time of infection and infer adherence to pre-exposure prophylaxis. Council OD , Ruone S , Mock PA , Khalil G , Martin A , Curlin ME , McNicholl JM , Heneine W , Leelawiwat W , Choopanya K , Vanichseni S , Cherdtrakulkiat T , Anekvorapong R , Martin M , Garcia-Lerma JG . AIDS 2019 33 (15) 2299-2307
HIV-1 genetic diversity to estimate time of infection and infer adherence to preexposure prophylaxis. Council OD , Ruone S , Mock PA , Khalil G , Martin A , Curlin ME , McNicholl JM , Heneine W , Leelawiwat W , Choopanya K , Vanichseni S , Cherdtrakulkiat T , Anekvorapong R , Martin M , Garcia-Lerma JG . AIDS 2019 33 (15) 2299-2307
Maintenance and reappearance of extremely divergent intra-host HIV-1 variants. Wertheim JO , Oster AM , Murrell B , Saduvala N , Heneine W , Switzer WM , Johnson JA . Virus Evol 2018 4 (2) vey030
Detailed Transmission Network Analysis of a Large Opiate-Driven Outbreak of HIV Infection in the United States. Campbell EM , Jia H , Shankar A , Hanson D , Luo W , Masciotra S , Owen SM , Oster AM , Galang RR , Spiller MW , Blosser SJ , Chapman E , Roseberry JC , Gentry J , Pontones P , Duwve J , Peyrani P , Kagan RM , Whitcomb JM , Peters PJ , Heneine W , Brooks JT , Switzer WM . J Infect Dis 2017 216 (9) 1053-1062
Transmission fitness of drug-resistant HIV revealed in a surveillance system transmission network. Wertheim JO , Oster AM , Johnson JA , Switzer WM , Saduvala N , Hernandez AL , Hall HI , Heneine W . Virus Evol 2017 3 (1) vex008
Antiretroviral drug activity in macaques infected during pre-exposure prophylaxis has a transient effect on cell-associated SHIV DNA reservoirs Cong ME , Pau CP , Heneine W , Garcia-Lerma JG . PLoS One 2016 11 (11) e0164821
1970s and 'Patient 0' HIV-1 genomes illuminate early HIV/AIDS history in North America. Worobey M , Watts TD , McKay RA , Suchard MA , Granade T , Teuwen DE , Koblin BA , Heneine W , Lemey P , Jaffe HW . Nature 2016 539 (7627) 98-101
Dual simian foamy virus/human immunodeficiency virus type 1 infections in persons from Cote d'Ivoire Switzer WM , Tang S , Zheng H , Shankar A , Sprinkle PS , Sullivan V , Granade TC , Heneine W . PLoS One 2016 11 (6) e0157709
Sensitive sentinel mutation screening reveals differential underestimation of transmitted HIV drug resistance among demographic groups. Li JF , Linley L , Kline R , Ziebell R , Heneine W , Johnson JA . AIDS 2016 30 (9) 1439-45
Longitudinal Detection and Persistence of Minority Drug-Resistant Populations and Their Effect on Salvage Therapy. Nishizawa M , Matsuda M , Hattori J , Shiino T , Matano T , Heneine W , Johnson JA , Sugiura W . PLoS One 2015 10 (9) e0135941
Highly-sensitive allele-specific PCR testing identifies a greater prevalence of transmitted HIV drug resistance in Japan. Nishizawa M , Hattori J , Shiino T , Matano T , Heneine W , Johnson JA , Sugiura W . PLoS One 2013 8 (12) e83150
Susceptibility to repeated, low-dose, rectal SHIVSF162P3 challenge is independent of TRIM5 genotype in rhesus macaques. Butler K , Morgan JS , Hanson DL , Adams DR , Garcia-Lerma G , Heneine PW , Ellenberger D , Hendry RM , McNicholl JM , Johnson W , Kersh EN . AIDS Res Hum Retroviruses 2013 29 (7) 1091-4
Human T-cell lymphotropic virus type 1 infection among U.S. thalassemia patients Switzer W , Shankar A , Trimble S , Thompson AA , Giardina PJ , Cohen AR , Coates TD , Vichinsky E , Neufeld EJ , Boudreaux JM , Heneine PW . AIDS Res Hum Retroviruses 2013 29 (7) 1006-9
Novel simian foamy virus infections from multiple monkey species in women from the Democratic Republic of Congo Switzer WM , Tang S , Ahuka-Mundeke S , Shankar A , Hanson DL , Zheng H , Ayouba A , Wolfe ND , Lebreton M , Djoko CF , Tamoufe U , Esteban A , Heneine W , Peeters M , Wright LL , Muyembe-Tamfum JJ , Wemakoy EO , Mulembakani P , Hoff NA , Rimoin AW . Retrovirology 2012 9 100
Prolonged tenofovir treatment of macaques infected with K65R reverse transcriptase mutants of SIV results in the development of antiviral immune responses that control virus replication after drug withdrawal Van Rompay KK , Trott KA , Jayashankar K , Geng Y , Labranche CC , Johnson JA , Landucci G , Lipscomb J , Tarara RP , Canfield DR , Heneine W , Forthal DN , Montefiori D , Abel K . Retrovirology 2012 9 57
Reduced inflammation and CD4 loss in acute SHIV infection during oral PrEP Kersh EN , Luo W , Zheng Q , Adams DR , Hanson D , Youngpairoj AS , Cong ME , Butler K , Hendry RM , McNicholl JM , Heneine W , Garcia-Lerma JG . J Infect Dis 2012 206 (5) 770-9
No evidence of murine leukemia virus-related viruses in live attenuated human vaccines. Switzer WM , Zheng H , Simmons G , Zhou Y , Tang S , Shankar A , Kapusinszky B , Delwart EL , Heneine W . PLoS One 2011 6 (12) e29223
Detection of murine leukemia virus or mouse DNA in commercial RT-PCR reagents and human DNAs. Zheng H , Jia H , Shankar A , Heneine W , Switzer WM . PLoS One 2011 6 (12) e29050
Measuring enzymatic HIV-1 susceptibility to two reverse transcriptase inhibitors as a rapid and simple approach to HIV-1 drug-resistance testing. Hoffmann D , Garcia AD , Harrigan PR , Johnston IC , Nakasone T , Garcia-Lerma JG , Heneine W . PLoS One 2011 6 (7) e22019
Transmission of human immunodeficiency virus and hepatitis C virus from an organ donor to four transplant recipients Ison MG , Llata E , Conover CS , Friedewald JJ , Gerber SI , Grigoryan A , Heneine W , Millis JM , Simon DM , Teo CG , Kuehnert MJ . Am J Transplant 2011 11 (6) 1218-1225
Protection against rectal transmission of an emtricitabine (FTC)-resistant SHIV162p3M184V mutant by intermittent prophylaxis with Truvada Cong ME , Youngpairoj AS , Zheng Q , Aung W , Mitchell J , Sweeney E , Hanson DL , Hendry RM , Dobard C , Heneine W , Garcia-Lerma JG . J Virol 2011 85 (15) 7933-6
No association of xenotropic murine leukemia virus-related viruses with prostate cancer. Switzer WM , Jia H , Zheng H , Tang S , Heneine W . PLoS One 2011 6 (5) e19065
Detection of low-level K65R variants in nucleoside reverse transcriptase inhibitor-naive chronic and acute HIV-1 subtype C infections. Li JF , Lipscomb JT , Wei X , Martinson NA , Morris L , Heneine W , Johnson JA . J Infect Dis 2011 203 (6) 798-802
Minority HIV mutation detection in dried blood spots indicates high specimen integrity and reveals hidden archived drug resistance. Wei X , Youngpairoj AS , Garrido C , Zahonero N , Corral A , de Mendoza C , Heneine W , Johnson JA , Garcia-Lerma JG . J Clin Virol 2010 50 (2) 148-52
Prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, U.S.-2006 Wheeler WH , Ziebell RA , Zabina H , Pieniazek D , Prejean J , Bodnar UR , Mahle KC , Heneine W , Johnson JA , Hall HI . AIDS 2010 24 (8) 1203-12
Emergence of a novel and highly divergent HTLV-3 in a primate hunter in Cameroon Zheng H , Wolfe ND , Sintasath DM , Tamoufe U , Lebreton M , Djoko CF , Diffo JL , Pike BL , Heneine W , Switzer WM . Virology 2010 401 (2) 137-45
Low-frequency K103N strengthens the impact of transmitted drug resistance on virologic responses to first-line efavirenz or nevirapine-based highly active antiretroviral therapy Geretti AM , Fox ZV , Booth CL , Smith CJ , Phillips AN , Johnson M , Li JF , Heneine W , Johnson JA . J Acquir Immune Defic Syndr 2009 52 (5) 569-73